What is the APUS stock price prediction for next 2 weeks?

According to our price prediction algorithm,Apimeds Pharmaceuticals US, Inc (APUS) price will be around $2.01 in the next 2 weeks. This means it will decrease by -23.745247148288968 from the last closing price. This prediction may vary from other time period filters for APUS stock.

What can be the highest Possible price of APUS stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, APUS can achieve the highest price of $2.71 which is 3.156862935658597 higher than last closing price. This prediction may vary from other time period filters for APUS stock.

What can be the lowest Possible price of APUS stock in next 2 weeks?

As per the forecast and algorithmic analysis, APUS stock price can be as low as $1.26 which is -52.07489621017998 lower than the current price in the next 2 weeks. This prediction may vary from other time period filters for APUS stock.

Will APUS stock go high in the next 2 weeks?

No, our stock forecasting algorithm shows that APUS stock will lose-23.745247148288968 in the next 2 weeks. This prediction may vary from other time period filters for APUS stock.

What is APUS stock last closing price?

Last closing price of APUS stock was $2.63.

What is APUS stock price prediction?

APUS stock price prediction means predicting the future closing prices of APUS stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of APUS stock in a certain time period.

How we predict APUS stock future prices?

If you are searching for APUS stock forecast, analysis or price prediction, then you might be wondering what Apimeds Pharmaceuticals US, Inc (APUS) will do in the future. Our APUS price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This APUS price prediction will likely answer most of your questions.

How frequent we update APUS stock predictions?

We are updating the forecasts for the APUS stock on daily basis.

Is using ML forecasting for APUS stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for APUS stock same for all the time periods?

No, the prediction for APUS stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

Apimeds Pharmaceuticals US, Inc Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$2.63-40.09%Since 2 Weeks

Predicted Price$2.01-23.75%For 2 Weeks

Upper Predicted Price$2.713.16%For 2 Weeks

Lower Predicted Price$1.26-52.07%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of APUS will decline by -23.75% over the next 2 Weeks and hit $2.01 by Wednesday, September 16, 2026. In that time frame, APUS's share price is expected to range between $1.26 and $2.71.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
Sep 16, 2026	1.26	2.01	2.71
Sep 15, 2026	1.73	2.46	3.16
Sep 14, 2026	1.42	2.11	2.77
Sep 11, 2026	1.46	2.13	2.89
Sep 10, 2026	1.56	2.27	3.02
Sep 9, 2026	1.73	2.43	3.18
Sep 8, 2026	2.16	2.88	3.62
Sep 7, 2026	1.82	2.54	3.21
Sep 4, 2026	1.86	2.56	3.29
Sep 3, 2026	2.03	2.70	3.41

APUS shares fell -25.71% in Wednesday, September 2, 2026's trading session, dropping from a previous close of $3.54 to move at $2.63. The stock demonstrated notable intraday movement (see APUS's key stats for a full breakdown), fluctuating between $2.51 and $3.38, a +34.66% trading range. While recent weeks have seen some volatility, APUS has managed to secure a -40.09% drop over the past 2 weeks. The downward price movement was accompanied by increased trading volume, with approximately 83.37K shares changing hands, 54.25K more than the previous session. This amounted to $219.27K in total market activity.

Will APUS Continue Its Upward Trend?

According to analyst ratings and projections for APUS, Apimeds Pharmaceuticals US, Inc shares are anticipated to increase by +3.06%, potentially reaching $2.71 per share by September 16, 2026. Short-term technical indicators for APUS currently suggest a bearish sentiment. This aligns with the stock's recent performance, as it has recorded 17 negative trading days within the past 30 sessions. Based on the APUS stock forecast, now is a good time to buy APUS stock because its current trading price is +31.14% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on APUS covering social and institutional perspectives.

APUS Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into APUS's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 20.90% to 30.30%) suggest the stock is experiencing strong bearish momentum. The 50-day RSI, at 38.65%, hints at potential weakness developing in the medium term. Additionally, the 100-day RSI, at 43.25%, maintains a neutral outlook for the long term. Insights into APUS's shareholder base show how institutional investors are positioning themselves during these momentum shifts

Apimeds Pharmaceuticals US Short-Term Forecasts

APUS Forecast For Next 5 Days

Our algorithm anticipates Apimeds Pharmaceuticals US (APUS) stock could hit $3.50 by Sep 09, 2026. This represents a +33.20% fall from today's price, following a -10.16% change over the past five days.

APUS Forecast For Next 30 Days

Based on analysis of market trends, the outlook for Apimeds Pharmaceuticals US, Inc (APUS) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $2.59, which would mean a -1.52% decrease from the current price of $2.63. Projections for this period range from a high of $4.64 to a low of $0.43.

APUS Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for Apimeds Pharmaceuticals US's price over the next three months point to a rise. APUS stock is expected to peak at $10.80 on Sep 28, 2026 before potentially dipping to $3.88 on Dec 03, 2026. On average, APUS is likely to trade around $7.31 in the coming 90 days.

Apimeds Pharmaceuticals US Stock Forecast 2025

Based on our predictive models, Apimeds Pharmaceuticals US (APUS) is expected to trade between $1.05 and $10.80 throughout 2026. This would result in an average price of $6.26, potentially offering investors a +138.02% return from current levels.

Apimeds Pharmaceuticals US, Inc Monthly Forecast 2026–2027

September 2026

According to our latest forecast models, Apimeds Pharmaceuticals US, Inc (APUS) is positioned to show a strong performance in September 2026. The price is predicted to move between $4.19 and $10.80, settling at an average of $8.55. This could translate to a +225.10% gain.

October 2026

Based on current market signals, Apimeds Pharmaceuticals US, Inc is projected to trend october 2026. We forecast a trading range from $4.48 to $9.87, with a likely average price of $6.39. Investors could expect a potential return of +142.97%.

November 2026

Our predictive algorithms indicate Apimeds Pharmaceuticals US, Inc stock may see a shift in November 2026. The expected range spans $4.41–$9.56, with an average target of $7.49. This represents a positive outlook and a possible gain of +184.79%.

December 2026

Analyzing established trends, Apimeds Pharmaceuticals US, Inc looks set to move in December 2026. Projections place the stock between $1.05 and $5.49, averaging around $3.01. This suggests a +14.45% gain from current levels.

January 2027

Market indicators suggest Apimeds Pharmaceuticals US, Inc could experience notable changes during January 2027. Prices could fluctuate within $0.96 to $2.80, with a midpoint forecast of $1.86. The stock might deliver a -29.28% loss.

February 2027

Forecasting for February 2027, models estimate that Apimeds Pharmaceuticals US, Inc may undergo key fluctuations. If trends hold, the stock might trade between $1.08 and $3.17, averaging $2.28. This signals a cautious trajectory with potential returns around -13.31%.

March 2027

According to our latest forecast models, Apimeds Pharmaceuticals US, Inc (APUS) is positioned to show a strong performance in March 2027. The price is predicted to move between $0.91 and $3.09, settling at an average of $1.95. This could translate to a -25.86% loss.

April 2027

Based on current market signals, Apimeds Pharmaceuticals US, Inc is projected to trend april 2027. We forecast a trading range from $1.30 to $3.33, with a likely average price of $2.33. Investors could expect a potential return of -11.41%.

May 2027

Our predictive algorithms indicate Apimeds Pharmaceuticals US, Inc stock may see a shift in May 2027. The expected range spans $0.08–$2.46, with an average target of $1.09. This represents a cautious outlook and a possible loss of -58.56%.

June 2027

Analyzing established trends, Apimeds Pharmaceuticals US, Inc looks set to move in June 2027. Projections place the stock between $0.00 and $1.56, averaging around $0.63. This suggests a -76.05% loss from current levels.

July 2027

Market indicators suggest Apimeds Pharmaceuticals US, Inc could experience notable changes during July 2027. Prices could fluctuate within $0.00 to $1.44, with a midpoint forecast of $0.64. The stock might deliver a -75.67% loss.

August 2027

Forecasting for August 2027, models estimate that Apimeds Pharmaceuticals US, Inc may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $1.06, averaging $0.35. This signals a cautious trajectory with potential returns around -86.69%.

September 2027

According to our latest forecast models, Apimeds Pharmaceuticals US, Inc (APUS) is positioned to show a strong performance in September 2027. The price is predicted to move between $0.00 and $1.00, settling at an average of $0.41. This could translate to a -84.41% loss.

APUS's history of dividends and stock splits also plays a role in long-term investor confidence.